拉夫米定 (Ｌａｍｉｖｕｄｉｎｅ ,商品名为贺普丁 )为核苷类抗病毒药物 ,１年来笔者观察了２８例慢性乙型肝炎 (以下简称乙肝 )患者的疗效 ,ＨＢＶ -ＤＮＡ转阴率达８５ %以上 ,现报告如下。临床资料一、病例选择年龄１０～５５岁 ,其中２０～４０岁占８０ %以上。男性２３例 Lamivudine (Lamivudine) is a kind of nucleoside antiviral drug. In the past one year, the author observed the curative effect of 28 patients with chronic hepatitis B (hereinafter referred to as hepatitis B), the HBV-DNA negative rate reached 85% The above report is as follows. Clinical data A case selection age 10 to 55 years old, of which 20 to 40 years accounted for more than 80%. 23 males